Empowering Surgeons in Patient-Specific Fracture Treatment
Our cutting-edge, AI-powered solution revolutionizes 3D pre-operative planning for orthopedic surgeons. By providing patient-specific insights, we enable surgeons to perform with exceptional accuracy, leading to improved patient outcomes and faster recovery
Our software was designed by a surgeon for surgeons, who was aware of the advantages of using 3D technologies but suffered from the limitations of the products available in the market.
That is why he decided to partner with VisionLab (UAntwerp and imec) to develop our core technology, with two proof-of-concept projects which lead to two patent applications thanks to the revolutionary approach.
Specifix spin-off in January 2023. Our complementary and multicultural team, has the perfect combination of medical, technical, and business experience to bring this product to the market.
Dr. Soha Mahdi:
Doctor in Artificial intelligence with expertise in medical applications.
Prof. Dr. MD. Matthias Vanhees:
Internationally renowned Hand & Wrist surgeon, active in research of 3D technologies.
Dr. Alejandra Ortega:
Doctor in Biomedical sciences with experience in the industry of medical devices.
At Specifix we are developing a fully automatic pre-operative planning software for patient-specific fracture treatment. Our unique AI-based solution supports orthopedic surgeons in selecting the best implant to use (surgical plate and screws) to stabilize fractures. Our software solves the problem of long surgeries, poor patient outcomes, and reduces medical waste and environmental impact.
Unlike our competitors, our software is fast and fully automatic, it does not require a specially trained operator which is expensive and time consuming. The surgeons can access the software via a website, making it easy to use from anywhere in the world 24/7.
Our initial application will be for wrist fractures, but we will soon expand the software to other joints such as the shoulder, knee, and ankle.
Since our incorporation two years ago, we have received significant (inter)national attention and support from important players in the eHealth ecosystem. Specifix has participated in the Deep Dive into Business by UAntwerpen and AMS, the EIT Health Women Entrepreneurship Bootcamp, and was selected by the prestigious imec.istart accelerator program, recognized as the world's top university-linked start-up accelerator by UBI Global. This esteemed affiliation has provided us with valuable resources, mentorship, and networking opportunities to accelerate the growth and success of our start-up. Moreover, we were also selected for the BlueHealth Innovation fund, which together account for 100,000€ for 9% of equity. Furthermore, we have received exceptional support and a convertible loan of 50,000€ from the University of Antwerp.
Address:
Lange Gasthuisstraat 29-31, 2000 Antwerpen @dunden
Copyright © All Rights Reserved
